<DOC>
	<DOCNO>NCT01154764</DOCNO>
	<brief_summary>This Phase I , open-labeled , randomization 2x2 Cross trial compare pharmacokinetic effect ketoconazole CG100649 healthy male volunteer .</brief_summary>
	<brief_title>Trial Studying Pharmacokinetic Effects Ketoconazole CG100649</brief_title>
	<detailed_description>- Adverse Events The whole study discontinuation determine base follow criterion Adverse Events classify use US NCI ( National Cancer Institute ) 'Common Terminology Criteria Adverse Events ( CTCAE ) - Pharmacokinetic assessment Real sampling time use calculate pharmacokinetic parameter . Concentrations low limit quantification , sampling applicable , miss data substitute `` &lt; LLOQ '' , `` NA '' , `` MD '' respectively . Pharmacokinetic analysis perform CG100649 .</detailed_description>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Age 1955 year old weight 50kg within 20 % ideal body weight 2 . No significant chronic/congenital disease 3 . Normal result lab test 4 . Ability inform consent 1 . History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric cognitive disorder . 2 . History gastrointestinal disorder ( bleed , ulceration , hemorrhoid , pile ) disorder absorption , distribution , metabolism , excretion . 3 . History known hypersensitivity drug include CG100649 . 4 . After take rest sit position 3 minute , subject low blood pressure ( Systolic BP ≤ 90 mmHg Diastolic BP ≤ 50 mmHg ) high blood pressure ( Systolic BP ≥ 150 mmHg Diastolic BP ≥ 100 mmHg ) .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>healthy male volunteer</keyword>
</DOC>